May 2015 Archives

Concerns about the economy sent the markets tumbling to a sharply lower close with the Dow plunging 115 points to 18,010. Nasdaq dropped 27 points to 5,070.

On the upside

Jiayuan.com International (Nasdaq: DATE) received a non-binding offer to take the company private from Vast Profit Holdings Ltd.

Bloomberg reported that Cigna (NYSE: CI) was exploring the possibility of buying Humana (NYSE: HUM).

UBS analyst Andrew Peters initiated coverage of Prothena (Nasdaq: PRTA) with a Buy rating and established a $58 price target.
 
On the downside

Investors locked in profits on Cellectis (Nasdaq: CLLS).

Frontline (NYSE: FRO) swung to a profit for the first quarter but revenue fell.

Bristol-Myers Squibb (NYSE: BMY) reported mixed interim data from a Phase I/II trial of Opdivo in advanced liver cancer patients.
 
In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 dropped 13 points to 2107. Bitcoin slipped $1 to $236. 

Losses extended as GDP shrinks

|
The markets extended its losses during the midday with the Dow tumbling 90 points to 18,065 as the nation's gross domestic product shrank by 0.7% in the first quarter. Nasdaq fell 13 points to 5,084.

On the upside

ITT Educational Services (NYSE: ESI) swung to a profit for 2014.

MagnaChip Semiconductor (NYSE: MX) narrowed first quarter losses more than expected prompting an upgrade.

Shares of Vascular Biogenics (Nasdaq: VBLT) continued rising.
 
On the downside

Pacific Sunwear (Nasdaq: PSUN) reported a wider than expected loss for the first quarter as revenue fell.

Greif (NYSE: GEF) cut its full year earnings guidance.

Investors continued to lock in profits on PlasmaTech Biopharmaceuticals (Nasdaq: PTBI).
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 fell 7 points to 2112. Bitcoin slipped $1 to $236.
The nation's economy contracted in the first quarter to weigh the market down to a lower open with the Dow dropping 60 points to 18,065. Nasdaq lost 12 points to 5,085.

On the upside

Transgenomic (Nasdaq: TBIO) launched its new Multiplexed ICE COLD-PCR (MS-ICP) CLIA to detect mutations in cancer patients.

Heron Therapeutics (Nasdaq: HRTX) reported positive results from a Phase 3 MAGIC study of SUSTOL.

An online abstract at the American Society of Clinical Oncology Annual Meeting 2015 highlighted Delcath Systems' (Nasdaq: DCTH) Hepatic CHEMOSAT Delivery System.
 
On the downside

Profit taking weighed down shares of Frontline (NYSE: FRO).

Investors locked in profits on One Horizon Group (Nasdaq: OHGI).

Splunk (Nasdaq: SPLK) widened first quarter losses.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on both the NYSE and on Nasdaq. The broader S&P 500 lost 4 points to 2116. Bitcoin slipped $1 to $236.
Jobless claims unexpectedly rose last week to weigh the markets down to a lower close with the Dow falling 36 points to 18,126. Nasdaq slipped 8 points to 5,097.

On the upside

Shares of Signal Genetics (Nasdaq: SGNL) continued climbing.

A federal judge granted Amarin's (Nasdaq: AMRN) request for a summary judgment in the biopharmaceutical's suit seeking Food and Drug Administration recognition of a five-year marketing exclusivity for Vascepa.

GoPro (Nasdaq: GPRO) chief executive Nick Woodman announced plans to develop a quadcopter and a Six-Camera Spherical Array.
 
On the downside

Investors locked in profits on Ceres (Nasdaq: CERE).

United Rentals (NYSE: URI) chief executive Michael Kneeland indicated that May revenue would fall short of expectations.

Profit taking weighed down shares of Delcath Systems (Nasdaq: DCTH).
 
In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 5 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 slipped 2 points to 2120. Bitcoin added $1 to $237.
The markets traded lower during the midday with the Dow losing 63 points to 18,099 as concerns that Greece may exit the eurozone resurfaced. Nasdaq fell 16 points to 5,090.

On the upside

Abercrombie & Fitch (NYSE: ANF) widened first quarter losses more than expected but the retailer expects sales to improve.

XOMA (Nasdaq: XOMA) announced that a Phase 3 EYEGUARD-B study reached its target exacerbation event.

A jury decided that Boston Scientific (NYSE: BSX) must pay $100 million to a woman for injuries sustained from the company's Pinnacle and Advantage Fit vaginal-mesh inserts but the stock price rose.
 
On the downside

Tilly's (NYSE: TLYS) reported higher first quarter earnings and revenue but the company forecast current quarter earnings below estimates.

Semtech (Nasdaq: SMTC) fell to a greater than expected loss for the first quarter and forecast current quarter results that missed estimates.

Xcerra (Nasdaq: XCRA) disappointed by falling to a loss for the third quarter and forecast fourth quarter results below expectations.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 lost 5 points to 2117. Bitcoin added $1 to $237.
An unexpected increase in first time applications for unemployment benefits sent the markets down to a lower open with the Dow falling 78 points to 18,084. Nasdaq lost 22 points to 5,084.

On the upside

One Horizon's (Nasdaq: OHGI) Aishuo now supports all major Chinese mobile payment platforms.

CA Technologies (Nasdaq: CA) will pay a premium of approximately $480 million to acquire Rally Software (NYSE: RALY).

An abstract at the 2015 Annual American Society of Clinical Oncology Meeting will highlight Biocept's (Nasdaq: BIOC) liquid biopsy diagnostic.
 
On the downside

Neostem (Nasdaq: NBS) priced its public offering of 12.5 million common shares at the discounted price of $2.00 per share.

E-Commerce China Dangdang (NYSE: DANG) fell to a loss for the first quarter.

SandRidge Energy (NYSE: SD) announced a private offering of $1.0 billion in senior secured notes.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 lost 5 points to 2118. Bitcoin added $1 to $237.

M&A activity lift markets

|
Merger and acquisition activity lifted the markets to a sharply higher close with the Dow leaping 121 points to 18,162. Nasdaq surged 73 points to 5,106.

On the upside

Avago Technologies engaged in advanced discussions to purchase Broadcom (Nasdaq: BRCM).

Reports that Greece has was drafting an agreement with its creditors lifted shares of National Bank of Greece (NYSE: NBG).

Idera Pharmaceuticals (Nasdaq: IDRA) will present at the Jefferies 2015 Global Healthcare Conference and at the 9th Annual JMP Securities Healthcare Conference.
 
On the downside

Yingli Green Energy (NYSE: YGE) reported lower full year earnings.

China Ming Yang Wind Power (NYSE: MY) reported sharply lower first quarter earnings even as revenue rose.

Investors continued to lock in profits on Youku Tudou (NYSE: YOKU).
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 soared 19 points to 2123. Bitcoin held steady at $236.

Markets continue soaring

|
The markets extended its gains during the midday with the Dow surging 133 points to 18,174. Nasdaq soared 64 points to 5,097.

On the upside

Ceres (Nasdaq: CERE) received a U.S. patent for a genetic sequence derived from soybean.

Galena Biopharma (Nasdaq: GALE) announced that two abstracts published by American Society of Clinical Oncology advanced the company's cancer immunotherapy programs NeuVax and GALE-301.

Retrophin (Nasdaq: RTRX) will sell its Rare Pediatric Disease Priority Review Voucher to Sanofi (NYSE: SNY).
 
On the downside

GlobeImmune (Nasdaq: GBIM) reported disappointing results from a Phase 2 study of GS-4774 to treat chronic hepatitis B.

Prima BioMed (Nasdaq: PBMD) partnered with Database Integrations to commercialize iCAN, the software platform powering Prima's CVac cellular therapy, but the stock price fell.

Shares of Shake Shack (NYSE: SHAK) continued falling.
 
In the broad market, advancing issues outpaced decliners by a margin of 7 to 3 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 soared 17 points to 2122. Bitcoin eased a fraction to $236.

Markets open higher

|
The market recovered from yesterday's steep losses to open higher with the Dow climbing 94 points to 18,137. Nasdaq gained 33 points to 5,066.

On the upside

Fortinet (Nasdaq: FTNT) will pay a premium of approximately $44 million in cash to acquire Meru Networks (Nasdaq: MERU).

Dawson James initiated coverage of Great Basin Scientific (Nasdaq: GBSN) with a Buy rating and a $10 price target.

Tiffany (NYSE: TIF) reported lower first quarter earnings and revenue but the results were better than expected.
 
On the downside

Michael Kors (NYSE: KORS) reported higher fourth quarter earnings and revenue but the results fell short of analyst expectations and the retailer forecast 2016 results below estimates.

Workday (NYSE: WDAY) narrowed first quarter losses more than expected as revenue soared but the stock price fell.

21Vianet Group (Nasdaq: VNET) narrowed losses for the first quarter but the stock price fell after Barron's said that the company was overvalued.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 gained 10 points to 2114. Bitcoin added $1 to $238.
Concerns that Greece's negotiations with creditors may stall sent the markets plummeting to close sharply lower with the Dow collapsing 190 points to 18,041. Nasdaq dove 56 points to 5,032.

On the upside

Barron's initiated coverage of Vascular Biogenics (Nasdaq: VBLT) with a Buy rating and a $13 price target.

Shares of Baozun (Nasdaq: BZUN) continued rising after making its Nasdaq debut last Thursday.

Calcalist reported that Nice Systems engaged in negotiations to buy LivePerson (Nasdaq: LPSN).
 
On the downside

Shares of Qunar Cayman Islands (Nasdaq: QUNR) fell after Priceline (Nasdaq: PCLN) announced an additional $250 million investment into Qunar rival Ctrip.com (Nasdaq: CTRP).

Tuniu (Nasdaq: TOUR) widened first quarter losses prompting a downgrade.

Tata Motors (NYSE: TTM) disappointed with sharply lower fourth quarter earnings that missed expectations by a wide margin and cancelled its full year dividend.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 4 to 1 on the NYSE and by more than 3 to 1 on Nasdaq. The broader S&P 500 plunged 21 points to 2104. Bitcoin held steady at $236.
Despite a stronger than expected increase in new home sales last month, the markets extended its losses during the midday with the Dow diving 189 points to 18,042. Nasdaq plunged 54 points to 5,034.

On the upside

Bargain hunters snapped up shares of FXCM (NYSE: FXCM).

Hot Topic will pay a premium of approximately $122 million to acquire Geeknet (Nasdaq: GKNT).

An affiliate of SFX Entertainment (Nasdaq: SFXE) chief executive Robert F.X. Sillerman will take the company private in a deal valued at approximately $774 million.
 
On the downside

Shares of Jumei International Holding (NYSE: JMEI) extended its losses.

Investors locked in profits on Shake Shack (NYSE: SHAK).

Concerns that Greece may not reach a deal to restructure its debt weighed down shares of National Bank of Greece (NYSE: NBG).
 
In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on the NYSE and by 7 to 2 on Nasdaq. The broader S&P 500 tumbled 20 points to 2105. Bitcoin added $1 to $237.
The markets opened sharply lower with the Dow plummeting 122 points to 18,109 as crude oil prices continued to fall. Nasdaq tumbled 43 points to 5,046.

On the upside

Prima BioMed (Nasdaq: PBMD) reported positive data from a Phase II CAN-003 ovarian cancer clinical trial.

The Food and Drug Administration granted Fast Track designation to IntelliPharmaCeutics International's (Nasdaq: IPCI) abuse deterrent Rexista Oxycodone extended-release tablets.

McDermott International (NYSE: MDR) won a brownfield contract from Saudi Aramco.
 
On the downside

Investors locked in profits on Youku Tudou (NYSE: YOKU).

RBC Capital downgraded First Solar (Nasdaq: FSLR) from a Sector Perform to an Underperform rating.

Retreating gold prices weighed down shares of Barrick Gold (NYSE: ABX) and Kinross Gold (NYSE: KGC).
 
In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 dropped 14 points to 2112. Bitcoin added $1 to $237.

U. S. markets closed

|
U. S. markets are closed for Memorial Day.
Retreating crude oil prices weighed the markets down to a lower close with the Dow dropping 53 points to 18,232. Nasdaq eased a point to 5,089.

On the upside

Canaccord Genuity upgraded ReWalk Robotics (Nasdaq: RWLK) from a Hold rating to a Buy rating.

E-Commerce China Dangdang (NYSE: DANG) will report first quarter earnings on May 28, 2015.

Bargain hunters lifted shares of Sarepta Therapeutics (Nasdaq: SRPT).
 
On the downside

Shares of China Information Technology (Nasdaq: CNIT) continued falling.

Profit taking weighed down shares of ChinaCache International (Nasdaq: CCIH).

Retreating crude oil prices weighed down shares of offshore drilling services provider SeaDrill (NYSE: SDRL).
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 slipped 4 points to 2126. Bitcoin added $1 to $236.
Crude oil prices slipped to weigh the markets down during the midday with the Dow falling 55 points to 18,229. Nasdaq edged up a point to 5,091.

On the upside

Eagle Rock Energy Partners (Nasdaq: EROC) will merge with a subsidiary of Vanguard National Resources (Nasdaq: VNR).

Shares of Shopify (NYSE: SHOP) continued soaring.

Youku Tudou (NYSE: YOKU) stock extended its gains.
 
On the downside

Otonomy (Nasdaq: OTIC) reported disappointing results from a Phase 2b trial of its unilateral Meniere's disease treatment OTO-104.

Chardan Capital Markets initiated coverage of Esperion Therapeutics (Nasdaq: ESPR) with a Sell rating.

Marvell Technology Group (NYSE: MRVL) reported sharply lower first quarter earnings as revenue fell and forecast current quarter results below expectations.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 7 to 5 on Nasdaq. The broader S&P 500 slipped 3 points to 2127. Bitcoin added $1 to $236.
The market markets opened mixed with the Dow losing 19 points to 18,266 while Nasdaq rose 7 points to 5,098 as consumer prices edged up 0.1%.

On the upside

Shares of Oncothyreon (Nasdaq: ONTY) continued to climb.

AVEO (Nasdaq: AVEO) stock extended its gains.

Ctrip (Nasdaq: CTRP) acquired a 37.6% stake in eLong (Nasdaq: LONG).
 
On the downside

Viggle (Nasdaq: VGGL) priced its public offering of approximately 3.6 million common shares at the discounted price of $2.50 per share.

Jumei International (NYSE: JMEI) reported higher first quarter earnings and revenue but the stock price fell.

Aeropostale (NYSE: ARO) reported a larger than expected loss for the first quarter as revenue fell.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by 5 to 4 on Nasdaq. The broader S&P 500 eased a point to 2129. Bitcoin held steady at $235.
The market closed flat with the Dow holding steady at 18,285 despite a greater than expected increase in first time applications for unemployment benefits. Nasdaq climbed 19 points to 5,090.

On the upside

Neostem (Nasdaq: NBS) received a $17.7 million grant from the California Institute for Regenerative Medicine.

Shares of Harvest Natural Resources (NYSE: HNR) rose again after reporting a narrower first quarter loss on Tuesday.

Covisint (Nasdaq: COVS) widened fourth quarter losses but revenue rose.
 
On the downside

Booz Allen Hamilton (NYSE: BAH) disappointed with lower fourth quarter earnings and revenue that fell short of analyst expectations.

Dicerna Pharmaceuticals (Nasdaq: DRNA) priced its public offering of 2.75 million common shares at the discounted price of $17.75 per share.

Chanticleer Holdings (Nasdaq: HOTR) widened losses for the first quarter.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 rose 4 points to 2130. Bitcoin added $1 to $235.
Rebounding crude oil prices lifted the markets during the midday with the Dow rising 12 points to 18,298. Nasdaq gained 18 points to 5,090.

On the upside

Youku Tudou (NYSE: YOKU) widened losses for the first quarter but revenue climbed to top estimates.

Shares of PGA Holdings (NYSE: PGND) surged on its first trading day.

Trina Solar (NYSE: TSL) received the Innovation Award for its Duo-Max module at the Mexico International Renewable Energy Conference.
 
On the downside

Xunlei (Nasdaq: XNET) reported a loss for the first quarter as revenue fell.

Open Text (Nasdaq: OTEX) announced that president and chief executive Mark J. Barrenechea will resume full involvement in day-to-day operations of the company and that the company will restructure its business to support its Cloud strategy.

Bruker (Nasdaq: BRKR) chief financial officer Charles F. Wagner, Jr. resigned.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 rose 5 points to 2131. Bitcoin added $2 to $236.
Jobless claims rose more than expected last week but the markets opened flat with the Dow adding 2 points to 18,288 as crude oil prices rebounded. Nasdaq rose 8 points to 5,080.

On the upside

Shares of AVEO Pharmaceuticals (Nasdaq: AVEO) continued rising.

Minutes were published from the European Medicines Agency meeting when the Committee for Orphan Medicinal Products recommended orphan designation for Prana Biotech's (Nasdaq: PRAN) Huntington disease treatment PBT2.

Shares of Shopify (NYSE: SHOP) surged on its first trading day.
 
On the downside

Profit taking weighed down shares of Prima Biomed (Nasdaq: PBMD).

NetApp (Nasdaq: NTAP) disappointed with lower fourth quarter earnings and revenue that fell short of analyst expectations and forecast current quarter results below estimates prompting a downgrade.

Lumber Liquidators (NYSE: LL) chief executive Robert Lynch unexpectedly resigned.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE while decliners edged out advancers by nearly 5 to 4 on Nasdaq. The broader S&P 500 added 2 points to 2128. Bitcoin rose $2 to $236.
Despite indications that the Federal Reserve would not raise interest rates in June, the markets closed lower with the Dow losing 26 points to 18,285. Nasdaq added a point to 5,071.

On the upside

Dycom Industries (NYSE: DY) reported sharply higher third quarter earnings that topped analyst estimates.

The Wall Street Journal reported that several potential suitors have approached Pep Boys (NYSE: PBY).

Shares of 500.com (NYSE: WBAI) continued climbing.
 
On the downside

CNinsure (Nasdaq: CISG) reported lower first quarter earnings that fell short of expectations.

Concerns that low fuel expenses will prompt airlines to cut air fares sent shares of American Airlines (Nasdaq: AAL), United Continental (NYSE: UAL) and Southwest (NYSE: LUV) tumbling.

Qihoo 360 Technology (NYSE: QIHU) reported higher first quarter earnings and revenue that surpassed expectations but the stock price fell.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 eased a point to 2125. Bitcoin held steady at $233.
The markets traded near the flatline during the midday with the Dow slipping 14 points to 18,297 as investors awaited the release of Federal Reserve meeting minutes. Nasdaq eased a fraction to 5,069.

On the upside

AVEO Pharmaceuticals (Nasdaq: AVEO) will present results from a Phase 3 TIVO-1 study of tivozanib to treat advanced renal cell carcinoma at the 2015 American Society of Clinical Oncology Annual Meeting.

Cablevision Systems (NYSE: CVC) sued Verizon alleging that Verizon falsely advertised that it uses 100% fiber optics.

Black Knight Financial Services (NYSE: BKFS) priced its public offering of 18 million common shares at $24.50 per share.
 
On the downside

EVINE Live (Nasdaq: EVLV) fell to a loss for the first quarter as revenue slipped.

Profit taking weighed down shares of Giga-tronics (Nasdaq: GIGA).

Shares of Eleven Biotherapeutics (Nasdaq: EBIO) continued falling.
 
In the broad market, declining issues were on par with advancers on the NYSE while decliners edged out advancers by nearly 5 to 4 on Nasdaq. The broader S&P 500 eased a point to 2126. Bitcoin added $1 to $234.
The markets opened flat with the Dow adding 5 points to 18,317 ahead of the release of Federal Reserve meeting minutes. Nasdaq slipped 4 points to 5,065.

On the upside

Prima Biomed (Nasdaq: PBMD) reported positive results from a Phase II clinical trial of its ovarian cancer treatment CAN-003.

Sarepta Therapeutics (Nasdaq: SRPT) will submit a rolling New Drug Application for its Duchenne muscular dystrophy treatment eteplirsen.

The Food and Drug Administration granted Orphan Drug Designation and Rare Pediatric Disease Designation to PlasmaTech Biopharmaceuticals' (Nasdaq: PTBI) ABX-101 and ABX-102.

On the downside

Achillion Pharmaceuticals (Nasdaq: ACHN) entered a worldwide license and collaboration agreement with Janssen Pharmaceuticals to develop one of Achillion's hepatitis C virus treatments but the stock price fell after rumors that Gilead (Nasdaq: GILD) was buying Achilion were quashed.

Etsy (Nasdaq: ETSY) reported an unexpected loss for the first quarter.

Lpath (Nasdaq: LPTN) reported disappointing results from a Phase 2 Nexus clinical trial of its wet age-related macular degeneration medication iSONEP. In light of the results, the company will reduce its workforce.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 eased a point to 2126. Bitcoin added $1 to $233.
Despite a surge in home construction, the markets closed mixed with the Dow rising 13 points to 18,312 as crude oil prices fell. Nasdaq lost 8 points to 5,070.

On the upside

Shares of PlasmaTech Biopharmaceuticals (Nasdaq: PTBI) continued rising.

Red Robin Gourmet Burgers (Nasdaq: RRGB) reported higher first quarter earnings that surpassed expectations by a wide margin.

AirMedia Group (Nasdaq: AMCN) widened first quarter losses as revenue fell but the stock price climbed.

On the downside

Stage Stores (NYSE: SSI) narrowed first quarter losses but revenue fell more than expected.

Atlas Resources Partners (NYSE: ARP) priced its public offering of 6.5 million common units at the discounted price of $7.97 per unit.

Profit taking weighed down shares of OraSure Technologies (Nasdaq: OSUR).
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 eased a point to 2127. Bitcoin edged up to $232.
The markets traded mixed during the midday with the Dow adding 5 points to 18,304 as retreating crude oil prices tempered enthusiasm for a surge in home construction. Nasdaq slipped 5 points to 5,072.

On the upside

500.com (NYSE: WBAI) fell to a loss for the first quarter but revenue rose and the company appointed Zhengming Pan to the position of chief executive officer.

Cheetah Mobile (NYSE: CMCM) reported sharply higher first quarter earnings and revenue that surpassed analyst expectations.

MagneGas (Nasdaq: MNGA) completed a MagneGas 2(R) presentation to a second top ten utility company in the nation.

On the downside

Roundy's (NYSE: RNDY) priced a secondary offering of 3.5 million common shares at the discounted price of $3.50 per share.

Linn Energy (Nasdaq: LINE) priced a public offering of 16 million common units at the discounted price of $11.79 per unit.

Intercept Pharmaceuticals (Nasdaq: ICPT) announced a Phase 3 clinical trial of obeticholic acid to treat patients with non-cirrhotic nonalcoholic steatohepatits with liver fibrosis but the trial would take longer to complete than investors had anticipated.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 held steady at 2129. Bitcoin added $1 to $233. 
Home construction soared 20.2% in April but the markets opened flat with the Dow slipping 7 points to 18,291. Nasdaq eased 2 points to 5,076.

On the upside

Giga-tronics (Nasdaq: GIGA) reported a loss for the fourth quarter but revenue surged and the company announced a $10 million multi-year production order of high performance YIG filters for a major aerospace firm.

Take-Two Interactive Software (Nasdaq: TTWO) reported a narrower than expected loss for the fourth quarter and forecast current quarter results ahead of estimates.

Momo (Nasdaq: MOMO) swung to a profit for the first quarter as revenue surged.

On the downside

Shares of Yingli Green Energy (NYSE: YGE) continued falling after yesterday's disclosure that it may face bankruptcy.

Kearny Financial (Nasdaq: KRNY) completed its stock offering and related conversion from a mutual holding company to the stock holding company.

Urban Outfitters (Nasdaq: URBN) disappointed with lower first quarter earnings that fell short of analyst expectations prompting downgrades.
 
In the broad market, advancing issues outpaced decliners by a margin of 5 to 4 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 added 6 points 2129. Bitcoin eased $1 to $234.
The markets closed modestly higher with the Dow rising 26 points to 18,298 as talks continued between Greece and its creditors. Nasdaq climbed 30 points to 5,078.

On the upside

PlasmaTech Biopharmaceuticals (Nasdaq: PTBI) closed its acquisition of Abeona Therapeutics. Also, H.C. Wainwright initiated coverage of PlasmaTech Biopharmaceuticals with a Buy rating

Shares of Resolute Energy (NYSE: REN) continued rising.

Jefferies upgraded Seventy Seven Energy (NYSE: SSE) from a Hold rating to a Buy rating.

On the downside

Yingli Green Energy (NYSE: YGE) said that it may not be able to meet its payment obligations.

Shares of ITT Educational Services (NYSE: ESI) fell again.

Goldman Sachs downgraded Petrobras (NYSE: PBR) from a Neutral rating to a Sell rating.
 
In the broad market, advancing issues outpaced decliners by a margin of 5 to 4 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 added 6 points 2129. Bitcoin eased $1 to $234.

Markets rise at midday

|
The markets advanced during the midday with the Dow rising 46 points to 18,319. Nasdaq gained 30 points to 5,078.

On the upside

Idera Pharmaceuticals (Nasdaq: IDRA) reported positive results from a Phase 1 clinical trial of IMO-9200.

Shares of MannKind (Nasdaq: MNKD) continued rising.

Stephens upgraded Cal-Maine Foods (Nasdaq: CALM) from an Equal Weight rating to an Overweight rating.

On the downside

InterCloud Systems (Nasdaq: ICLD) entered a securities purchase agreement.

Shares of 500.com (NYSE: WBAI) fell ahead of its earnings release tomorrow before market open.

First quarter earnings fell for Fifth Street Asset Management (Nasdaq: FSAM).
 
In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while advancers outpaced decliners by more than 3 to 2 on Nasdaq. The broader S&P 500 gained 7 points 2129. Bitcoin held steady at $236.
The markets opened flat with the Dow slipping 2 points to 18,270 while Nasdaq added a point to 5,049 as talks between Greece and its creditors continued with little progress.

On the upside

Ascena Retail Group will pay approximately $2.16 billion in cash and stock to acquire Ann Taylor (NYSE: ANN).

Four U. S. electric utility companies requested that the U. S. Nuclear Regulatory Commission review Lightbridge's (Nasdaq: LTBR) patented metallic fuel design.

OraSure Technologies (Nasdaq: OSUR) president and chief executive Douglas A. Michels will ring the Nasadaq Opening Bell on Tuesday, May 19.

On the downside

Eleven Biotherapeutics (Nasdaq: EBIO) reported disappointing results from a Phase 3 study of its dry-eye disease treatment EBI-005.

Profit taking weighed down shares of MagneGas (Nasdaq: MNGA).

Shares of Weibo (Nasdaq: WB) extended its losses.
 
In the broad market, declining issues outpaced advancers by a margin of 3 to 2 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 held steady at 2122. Bitcoin added $1 to $237.
The markets closed modestly higher with the Dow rising 20 points to 18,232 as crude oil prices edged up. Nasdaq slipped 2 points to 5,048.

On the upside

Harvest Natural Resources (NYSE: HNR) will release first quarter earnings on Tuesday, May 19.

NantPharm will purchase Sorrento Therapeutics (Nasdaq: SRNE) subsidiary Igdrasol, which has been developing the cancer treatment Cynviloq.

First quarter earnings and revenue surged for SkyPeople Fruit Juice (Nasdaq: SPU).

On the downside

RMG Networks (Nasdaq: RMGN) will issue nearly 25 million shares of common stock.

hhgregg (NYSE: HGG) widened losses more than expected as revenue slipped to fall short of estimates.

MakeMyTrip (Nasdaq: MMYT) reported a wider than expected loss for the fourth quarter.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 added a point to 2122. Bitcoin added $1 to $238.
The markets opened lower with the Dow losing 20 points to 18,232 as crude oil prices retreated. Nasdaq fell 12 points to 5,038.

On the upside

BSQUARE (Nasdaq: BSQR) reported higher first quarter earnings and revenue.

Shares of Oncothyreon (Nasdaq: ONTY) continued rising.

Avis Budget Group (Nasdaq: CAR) stock advanced again on Wednesday's announcement that the company would be the exclusive car rental partner for Pebble Beach Resorts.

On the downside

El Pollo Loco (Nasdaq: LOCO) reported higher first quarter earnings and revenue but investors were disappointed with the company's full year earnings guidance.

Bloomberg reported that Keurig Green Mountain (Nasdaq: GMCR) would roll out its new Keurig Kold cold brewing system more slowly than anticipated.

Standard & Poor's Ratings Services cut the corporate credit rating on SandRidge Energy (NYSE: SD) from B to CCC+.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 10 to 9 on both the NYSE and on Nasdaq. The broader S&P 500 eased a fraction to 2120. Bitcoin added $1 to $238.
A strong jobs report sent the markets soaring with the Dow jumping 191 points to 18,239. Nasdaq leaped 69 points to 5,050.

On the upside

Youku Tudou (NYSE: YOKU) will release first quarter earnings on May 20, 2015.

Clovis Oncology (Nasdaq: CLVS) will present data at the 2015 American Society of Clinical Oncology Annual Meeting about three compounds in advanced clinical development.

Qiwi (Nasdaq: QIWI) reported higher first quarter earnings and announced plans to buy Otkritie Financial Group's Contact money transfer system and the Rapida payment processing system.

On the downside

Gevo (Nasdaq: GEVO) priced its public offering of 4.3 million common shares at the discounted price of $4 per share.

Discovery Laboratories (Nasdaq: DSCO) reported encouraging data from a Phase 2a clinical trial of AEROSURF and will proceed to a Phase 2 clinical program but the stock price fell.

J.C. Penney (NYSE: JCP) narrowed losses for the first quarter but investors remain concerned about the retailer's turnaround plan.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 surged 22 points to 2121. Bitcoin added $1 to $237.
An unexpected drop in jobless claims sent the markets soaring during the midday with Dow surging 179 points to 18,239. Nasdaq jumped 59 points to 5,040.

On the upside

Forbes Energy Services (Nasdaq: FES) widened first quarter losses but the results were better than expected.

Shares of Galapagos (Nasdaq: GLPG) surged on its first trading day.

Atossa Genetics (Nasdaq: ATOS) widened first quarter losses but revenue surged.

On the downside

Shares of Kandi Technologies Group (Nasdaq: KNDI) continued falling.

Puma Biotechnology (NYSE: PBYI) reported mixed results for its breast cancer treatment PB272.

Investors locked in profits on One Horizon Group (Nasdaq: OHGI).
 
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 soared 18 points to 2117. Bitcoin held steady at $236.
The markets opened sharply higher with Dow leaping 159 points to 18,220 as first time applications for unemployment benefits fell. Nasdaq surged 40 points to 5,022.

On the upside

VBL Therapeutics (Nasdaq: VBLT) will present positive interim data from a Phase 1/2 clinical trial of its platinum-resistant Mullerian cancer treatment VB-111.

Ctrip.com (Nasdaq: CTRP) fell to a loss for the first quarter but the results were better than expected prompting upgrades.

Bargain hunters lifted shares of Oncothyreon (Nasdaq: ONTY).

On the downside

First quarter earnings rose for Kohl's (NYSE: KSS) but the results fell short of expectations.

Profit taking weighed down shares of Giga-tronics (Nasdaq: GIGA).

Jones Energy (NYSE: JONE) priced its secondary offering of 5 million common shares at the discounted price of $10 per share.
 
In the broad market, advancing issues outpaced decliners by a margin of 4 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 climbed 15 points to 2113. Bitcoin added $1 to $237.

Mixed close on economic data

|
The markets closed mixed with Dow slipping 7 points to 18,060 as crude oil inventories fell while retail sales held steady. Nasdaq added 5 points to 4,981.

On the upside

Giga-tronics (Nasdaq: GIGA) received a $3 million order for its high performance YIG filters.

Rentrak (Nasdaq: RENT) reported higher fourth quarter revenue prompting an upgrade.

Zebra Technologies (Nasdaq: ZBRA) fell to a loss for the first quarter but the results were better than expected.

On the downside

Barclays said that FXCM (NYSE: FXCM) had limited upside potential.

AES (NYSE: AES) priced its secondary offering of approximately 60 million common shares at the discounted price of $13.25 per share.

TowerJazz (Nasdaq: TSEM) fell to a loss for the first quarter.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 eased a fraction to 2098. Bitcoin added $1 to $242. 
The markets traded higher during the midday with Dow adding 17 points to 18,085 as crude oil inventories fell. Nasdaq gained 17 points to 4,994.

On the upside

NTELOS Holdings (Nasdaq: NTLS) presented at the Jefferies 2015 TMT Conference in Miami this morning.

The Food and Drug Administration granted rare pediatric disease designation to Fibrocell Science's (Nasdaq: FCSC) orphan gene-therapy drug candidate FCX-007 to treat recessive dystrophic epidermolysis bullosa.

Silver Strand Resources (Nasdaq: SSRI) swung to a profit for the first quarter as revenue surged.

On the downside

EZchip Semiconductor (Nasdaq: EXCH) fell to a loss for the first quarter and announced that the company's largest client chose to use EZchip's NP-5 network processor rather than the NPS-400 in the customer's next generation line cards.

Star Bulk Carriers (Nasdaq: SBLK) priced its public offering of 56.25 million common shares at the discounted price of $3.20 per share.

Post Holdings (NYSE: POST) announced that the avian flu has affected approximately 20% of its egg supply.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE while decliners barely edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 added 3 points to 2102. Bitcoin added $1 to $242. 
The markets opened higher with Dow gaining 52 points to 18,120 despite flat April retail sales. Nasdaq climbed 28 points to 5,004.

On the upside

Williams Cos. (NYSE: WMB) will acquire Williams Partners (NYSE: WPZ) in an all stock deal valued at approximately $13.8 billion.

Gevo (Nasdaq: GEVO) narrowed losses for the first quarter as revenue surged.

Downloads of One Horizon Group's (Nasdaq: OHGI) Aishuo smartphone app surpassed 3 million.

On the downside

ResMed (NYSE: RMD) reported disappointing results from a Phase III trial of its sleep apnea treatment Adaptive Servo-Ventilation therapy.

Takeda Pharmaceutical has informed Orexigen Therapeutics (Nasdaq: OREX) that Takeda will end their collaboration agreement.

DuPont (NYSE: DD) shareholders rejected all four board nominees submitted by activist investor Nelson Peltz's Trian Fund Management.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 3 on the NYSE and by 3 to 2 on Nasdaq. The broader S&P 500 gained 7 points to 2106. Bitcoin added $1 to $242. 
The markets closed lower with Dow losing 36 points to 18,068 as Greece made an interest payment on its debt. Nasdaq fell 17 points to 4,976.

On the upside

Ocean Rig UDW (Nasdaq: ORIG) reversed year ago losses to post a greater than expected profit for the first quarter as revenue climbed.

SciClone Pharmaceuticals (Nasdaq: SCLN) reported sharply higher first quarter earnings that nearly doubled as revenue soared.

Armistice Capital acquired a 5.4% stake in Spectrum Pharmaceuticals (Nasdaq: SPPI) and has asked that the company sell itself.

On the downside

American Public Education (Nasdaq: APEI) disappointed with lower first quarter earnings and revenue.

Orexigen Therapeutics (Nasdaq: OREX) and Takeda Pharmaceuticals terminated the cardiovascular outcomes trial for the obesity treatment Contrave.

MasTec (NYSE: MTZ) fell to a greater than expected loss for the first quarter and forecast current quarter and full year results below estimates.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by more than 5 to 4 on Nasdaq. The broader S&P 500 lost 6 points to 2099. Bitcoin held steady at $241. 
The markets recovered early morning losses but continued to trade in negative territory with Dow dropping 51 points to 18,053 over concerns about Greece's financial situation. Nasdaq lost 16 points to 4,976.

On the upside

Shares of EQT GP Holdings (NYSE: EQGP) surged on its first trading day.

The Wall Street Journal reported that Pall (NYSE: PALL) would close an auction to sell itself later this week.

First quarter earnings slipped for FMSA Holdings (NYSE: FMSA) but the results were better than expected.

On the downside

The Securities and Exchange Commission charged ITT Educational Services (NYSE: ESI), chief executive Kevin Modany and chief financial officer Daniel Fitzpatrick with fraud.

DepoMed (Nasdaq: DEPO) fell to a greater than expected loss for the first quarter.

First quarter earnings slipped for WageWorks (NYSE: WAGE) prompting Stifel Nicolaus to cut its price target on the company from $66 to $55.
 
In the broad market, declining issues outpaced advancers by a margin of 3 to 2 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 lost 7 points to 2097. Bitcoin held steady at $241.
Renewed concerns that Greece may exit the eurozone sent the markets down to a sharply lower open with Dow plummeting 116 points to 17,988. Nasdaq tumbled 47 points to 4,946.

On the upside

Verizon (NYSE: VZ) will pay a premium of approximately $4.4 billion to acquire AOL (NYSE: AOL).

Pain Therapeutics (Nasdaq: PTIE) announced positive top-line results from a Human Abuse Potential Study with REMOXY extended release capsules.

The Food and Drug Administration granted Fast Track designation to Threshold Pharmaceuticals' (Nasdaq: THLD) development partner Merck KGaA, Darmstadt, Germany for the development of evofosfamide.

On the downside

Noranda Aluminum (NYSE: NOR) priced a secondary offering of 22.84 million common shares.

Rackspace Holding (NYSE: RAX) reported higher first quarter earnings and revenue but the company forecast current quarter revenue that fell short of expectations prompting a downgrade.

NewLink Genetics (Nasdaq: NLNK) will continue a Phase 3 pancreatic cancer trial without modifications.
 
In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on the NYSE and by nearly 3 to 1 on Nasdaq. The broader S&P 500 fell 17 points to 2088. Bitcoin held steady at $241.
Uncertainty over Greek debt weighed the markets down to a lower close with Dow tumbling 85 points to 18,105. Nasdaq slipped 9 points to 4,993.

On the upside

PlasmaTech Biopharmaceuticals (Nasdaq: PTBI) closed a $10 million private placement.

Nevro (NYSE: NVRO) widened losses for the first quarter but revenue soared and the Food and Drug Administration approved the company's Senza spinal cord stimulation system.

Shares of InterCloud Systems (Nasdaq: ICLD) continued climbing.

On the downside

Shares of ForceField Energy (Nasdaq: FNRG) resumed trading today, three weeks after chairman Richard St. Julien was arrested for securities fraud.

RadNet (Nasdaq: RDNT) reported a wider than expected loss for the first quarter.

Oncothyreon (Nasdaq: ONTY) reported a loss for the first quarter.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE while advancers edged out decliners nearly 10 to 9 on Nasdaq. The broader S&P 500 lost 10 points to 2105. Bitcoin added $1 to $241.
The markets turned negative during the midday with Dow dropping 64 points to 18,126 as Greece and the Eurozone have yet to reach a deal one day before a debt payment from Greece is due to the International Monetary Fund. Nasdaq held steady at 5,003.

On the upside

On Assignment (NYSE: ASGN) will pay approximately $570 million to acquire privately held Creative Circle.

Nuverra Environmental Solutions (NYSE: NES) narrowed first quarter losses more than expected.

Clean Diesel Technologies (Nasdaq: CDTI) will supply the New York City Department of Sanitation vehicles with the DuraFit diesel particulate filters.

On the downside

Wedbush downgraded Etsy (Nasdaq: ETSY) from a Neutral rating to an Underperform rating.

Shares of C&J Energy Services (NYSE: CJES) continued falling.

Comstock Resources (NYSE: CRK) fell to a loss for the first quarter.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE while advancers edged out decliners 5 to 3 on Nasdaq. The broader S&P 500 fell 7 to 2109. Bitcoin added $3 to $243.
The markets opened flat with Dow slipping 7 points to 18,183 as negotiations between Greece and its lenders continued. Nasdaq rose 10 points to 5,014.

On the upside

Noble Energy (NYSE: NBL) will pay a premium of approximately $2.1 billion to acquire Rosetta Resources (Nasdaq: ROSE).

Viggle (Nasdaq: VGGL) widened third quarter losses but revenue surged and net registered users more than doubled.

Alibaba (NYSE: BABA) increased its stake in zulily (Nasdaq: ZU) to more than 9%.

On the downside

FXCM (NYSE: FXCM) fell to a loss for the first quarter and a pension fund sued the company alleging fraud.

Gevo (Nasdaq: GEVO) extended its losses.

Shares of MannKind (Nasdaq: MNKD) continued falling.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and more than 7 to 5 on Nasdaq. The broader S&P 500 held steady at 2116. Bitcoin held steady at $242.
The markets soared to a sharply higher close with Dow leaping 267 points to 18,191 as the unemployment rate slipped. Nasdaq surged 58 points to 5,003.

On the upside

NeoPhotonics (NYSE: NPTN) swung to a profit for the first quarter as revenue climbed.

Silver Springs Networks (NYSE: SSNI) reversed year ago losses to post a better than expected profit for the first quarter as revenue surged.

Imperva (NYSE: IMPV) reported a loss for the first quarter but the results were better than expected and the company forecast current quarter and full year results ahead of estimates.

On the downside

Pros Holdings (NYSE: PRO) widened losses and forecast current quarter and full year results that missed expectations prompting a downgrade.

bebe stores (Nasdaq: BEBE) reported a loss for the third quarter and suspended its dividend payments.

EnerNOC (Nasdaq: ENOC) widened first quarter losses as revenue slipped.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and more than 5 to 3 on Nasdaq. The broader S&P 500 soared 28 points to 2116. Bitcoin held steady at $242.
A drop in the nation's unemployment rate boosted the markets during the midday with Dow rocketing 263 points to 18,187. Nasdaq leaped 64 points to 5,009.

On the upside

Shares of Bojangles' (Nasdaq: BOJA) surged on its first trading day.

Calithera Biosciences (Nasdaq: CALA) reported a loss for the first quarter but the company continued to expand and advance it development pipeline.

Aerie Pharmaceuticals (Nasdaq: AERI) widened losses for the first quarter but the stock price rose.

On the downside

Planar Systems (Nasdaq: PLNR) reported higher second quarter earnings and revenue but the company forecast full year results below expectations.

First quarter earnings plunged for Monster Beverage (Nasdaq: MNST) to fall short of expectations.

Sprouts Farmers Market (Nasdaq: SFM) reported higher first quarter earnings and revenue but the results missed estimates.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 1 on the NYSE and nearly 7 to 3 on Nasdaq. The broader S&P 500 soared 28 points to 2116. Bitcoin rose $4 to $242.
The markets surged to a sharply higher open with Dow leaping 256 points to 18,180 as the nation's unemployment rate dropped to its lowest level in nearly seven years. Nasdaq jumped 60 points to 5,005.

On the upside

Shares of Gevo (Nasdaq: GEVO) continued soaring.

InterCloud Systems (Nasdaq: ICLD) won a contract with a major auto parts distributor to design, migrate and implement a cloud solution to house a web service infrastructure.

Novogen (Nasdaq: NVGN) reported positive preclinical results for the experimental cancer treatment TRXE-009.

On the downside

BioScrip (Nasdaq: BIOS) reported a greater than expected loss for the first quarter.

MannKind (Nasdaq: MNKD) reported a loss for the first quarter.

Fluidigm (Nasdaq: FLDM) reported a loss for the first quarter as revenue fell short of expectations and the company forecast full year revenue below estimates.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 11 to 1 on the NYSE and nearly 5 to 1 on Nasdaq. The broader S&P 500 soared 24 points to 2112. Bitcoin edged up to $238.
Upbeat jobless claims data lifted the markets to a higher close with Dow climbing 82 points to 17,924. Nasdaq gained 25 points to 4,945.

On the upside

The Wall Street Journal reported that Yelp (NYSE: YELP) was exploring a possible sale of the company.

SodaStream International (NYSE: SODA) reported lower first quarter earnings but the results surpassed analyst expectations by a wide margin.

SunEdison (Nasdaq: SUNE) narrowed losses for the first quarter.

On the downside

Sequenom (Nasdaq: SQNM) reversed year ago losses to post a profit for the first quarter but revenue fell short of analyst estimates prompting a downgrade.

Sucampo Pharmaceuticals (Nasdaq: SCMP) reported higher first quarter earnings but revenue missed expectations.

Shares of PlasmaTech Biopharmaceuticals (Nasdaq: PTBI) continued dropping.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 2088. Bitcoin added $6 to $237. 
First time applications for unemployment benefits edged up less than expected to lift the markets higher during the midday with Dow soaring 114 points to 17,956. Nasdaq gained 32 points to 4,952.

On the upside

Chegg (NYSE: CHGG) reported a loss for the first quarter but revenue rose to top analyst estimates and the company lifted its full year forecast.

Castlight Health (NYSE: CSLT) narrowed first quarter losses more than expected as revenue surged.

Career Education (Nasdaq: CECO) narrowed losses for the first quarter and announced plans to focus its resource on its university group.

On the downside

Dex Media (Nasdaq: DXM) narrowed first quarter losses but revenue fell.

First quarter earnings fell for Tumi (NYSE: TUMI).

Varonis Systems (Nasdaq: VRNS) widened losses more than expected for the first quarter and lowered its full year outlook prompting a downgrade.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on the NYSE while advancers barely edged out decliners by a slim margin on Nasdaq. The broader S&P 500 gained 11 points to 2091. Bitcoin added $2 to $233.
The markets opened lower with Dow losing 34 points to 17,807 as crude oil price retreated. Nasdaq slipped 4 points to 4,915.

On the upside

Funds advised by Apex Partners will acquire Quality Distribution (Nasdaq: QLTY) for a premium of approximately $800 million including the assumption of debt.

Alaska Airlines partnered with Gevo (Nasdaq: GEVO) to use Gevo's renewable alcohol-to-jet fuel.

Alibaba Group (NYSE: BABA) named David Zhang to the position of chief executive officer.

On the downside

iCAD (Nasdaq: ICAD) announced that Noridian changed the reimbursement code for electronic brachytherapy for non-melanoma skin cancers.

Whole Foods Market (Nasdaq: WFM) reported higher second quarter earnings and revenue but revenue fell short of expectations and the company forecast full year revenue below estimates.

Nu Skin Enterprises (NYSE: NUS) disappointed with lower first quarter earnings and revenue and forecast current quarter and full year results that fell short of expectations.
 
In the broad market, declining issues outpaced advancers by a margin of 5 to 4 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 lost 4 points to 2076. Bitcoin added $1 to $232.
Weak economic data weighed the markets down to a lower close with Dow dropping 86 points to 17,841. Nasdaq tumbled 19 points to 4,919.

On the upside

InterCloud Systems (Nasdaq: ICLD) won a $1.5 million network expansion contract with New York City's largest provider of family services.

Walker & Dunlop (NYSE: WD) reported sharply higher first quarter earnings and revenue that surpassed analyst expectations.

Trovagene (Nasdaq: TROV) widened first quarter losses but revenue rose and the company expanded lung cancer clinical study programs.

On the downside

TriNet Group (NYSE: TNET) reported higher first quarter earnings and revenue but the stock price fell.

First quarter earnings dropped for Crestwood Equity Partners (NYSE: CEQP).

Enphase Energy (Nasdaq: ENPH) widened losses for the first quarter prompting a downgrade.
 
In the broad market, declining issues outpaced advancers by a margin of 5 to 2 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 fell 9 points to 2080. Bitcoin slipped $1 to $234.
The nation's private employers hired fewer workers than expected in April to weigh the markets down during the midday with Dow tumbling 85 points to 17,842. Nasdaq fell 16 points to 4,922.

On the upside

Herbalife (NYSE: HLF) reported higher first quarter earnings that surpassed analyst expectations by a wide margin and lifted its full year earnings outlook.

Bloomberg reported that Western Union (NYSE: WU) initiated discussions for a possible acquisition of Moneygram International (Nasdaq: MGI).

Fate Therapeutics (Nasdaq: FATE) entered a strategic research collaboration agreement with Juno Therapeutics (Nasdaq: JUNO) to improve genetically engineered T cell immunotherapies.

On the downside

TetraLogic Pharmaceuticals (Nasdaq: TLOG) temporarily halted enrollment in a chronic hepatitis B trial.

Skullcandy (Nasdaq: SKUL) widened first quarter losses and forecast current quarter results below expectations.

Shares of CoLucid Pharmaceuticals (Nasdaq: CLCD) fell on its first trading day.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 lost 6 points to 2082. Bitcoin held steady at $235.
A drop in the nation's productivity along with disappointing job growth sent the markets tumbling to a sharply lower open with Dow plunging 90 points to 17,837. Nasdaq lost 16 points to 4,923.

On the upside

PlasmaTech Biopharmaceuticals (Nasdaq: PTBI) will acquire Abeona Therapeutic for approximately 3.98 million common shares.

Alexion Pharmaceuticals (Nasdaq: ALXN) will pay a premium of approximately $8.4 billion in cash and stock to acquire Synageva BioPharma (Nasdaq: GEVA).

Borderfree (Nasdaq: BRDR) will be acquired by Pitney Bowes for a premium of approximately $395 million in cash.

On the downside

Zulily (Nasdaq: ZU) reported a loss for the first quarter and lowered it full year revenue outlook.

Anadigics (Nasdaq: ANAD) narrowed losses for the first quarter but revenue fell.

Noodles & Co. (Nasdaq: NDLS) fell to a loss for the first quarter and forecast full year revenue below expectations.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 lost 7 points to 2081. Bitcoin eased to $234.

Greek concerns sink stocks

|
Concerns over Greece's ability to renegotiate the terms of its bailout sent the markets tumbling to a sharply lower close with Dow plummeting 142 points to 17,928. Nasdaq sank 77 points to 4,939.

On the upside

Abiomed (Nasdaq: ABMD) impressed with sharply higher fourth quarter earnings and revenue that beat analyst expectations and lifted its 2016 revenue guidance.

Bloomberg reported that Quebec may purchase a rail line and port facilities that support the Bloomfield Lake mining site owned by Cliffs Natural Resources (NYSE: CLF) .

EarthLink (Nasdaq: ELNK) narrowed first quarter losses more than expected.

On the downside

Second quarter earning slipped for Kulicke & Soffa (Nasdaq: KLIC) to fall short of expectations and the company forecast current quarter revenue below estimates.

PTC Therapeutics (Nasdaq: PTCT) widened first quarter losses as revenue fell prompting a downgrade.

NeoStem (Nasdaq: NBS) widened losses for the first quarter on lower revenue.
 
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 2 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 plunged 25 points to 2089. Bitcoin slipped $2 to $235.
The markets tumbled during the midday with Dow plunging 97 points to 17,972 as negotiations between Greece and the Eurozone continued without any resolution. Nasdaq plummeted 70 points to 4,946.

On the upside

First quarter earnings and revenue slipped for RetailMeNot (Nasdaq: SALE) but the results were better than expected.

Chuy's (Nasdaq: CHUY) reported hight first quarter earnings and revenue and lifted its full year earnings outlook.

Nautilus (NYSE: NLS) impressed with sharply higher first quarter earnings and revenue that surpassed expectations.

On the downside

Nationstar Mortgage (NYSE: NSM) fell to a greater than expected loss for the first quarter on lower revenue.

The New York Post reported that several potential suitors of Avon Products (NYSE: AVP) are no longer interested in acquiring the beauty products company.

On Deck Pharmaceutical (NYSE: ONDK) reported a loss for the first quarter.
 
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 2 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 tumbled 21 points to 2093. Bitcoin slipped $2 to $235.
The markets opened lower with Dow losing 42 points to 18,027 as the nation's trade deficit climbed to a six-year high. Nasdaq dropped 45 points to 4,971.

On the upside

Billionaire investor George Soros acquired a 5.17% stake in PlasmaTech Biopharmaceuticals (Nasdaq: PTBI).

Golar LNG (Nasdaq: GLNG) entered negotiations for a third GoFLNG vessel.

Clean Diesel Technologies (Nasdaq: CDTI) reported positive preliminary test results for its new synergized-platinum group metal diesel oxidation catalyst technology.

On the downside

Qualys (Nasdaq: QLYS) swung to a profit for the first quarter but the company forecast current quarter results that fell short of analyst expectations.

Investors locked in profits on InterCloud Systems (Nasdaq: ICLD).

The Food and Drug Administration's Division of Anesthesia, Analgesia, and Addiction Products denied a request for a meeting made by AcelRx Pharmaceuticals (Nasdaq: ACRX) to discuss test results for the pain medication Zalviso.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 9 to 7 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 lost 7 points to 2106. Bitcoin slipped $3 to $234.
It was a higher close for the markets with Dow gaining 46 points to 18,070 over earnings news. Nasdaq rose 11 points to 5,016.

On the upside

Shares of Digital Ally (Nasdaq: DGLY) extended its gains.

BroadSoft (Nasdaq: BSFT) narrowed first quarter losses more than expected as revenue climbed.

Array BioPharma (Nasdaq: ARRY) reversed year ago losses to post a stronger than expected profit for the third quarter.

On the downside

Shares of National Bank of Greece (NYSE: NBG) fell as Greece struggled to avert bankruptcy.

Citigroup downgraded Sibanye Gold (NYSE: SBGL) from a Neutral rating to a Sell rating.

MobileIron (Nasdaq: MOBL) partnered with Tangoe (Nasdaq: TNGO) to integrate and deliver globally available mobility managed services but the stock price fell.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 5 on both the NYSE and on Nasdaq. The broader S&P 500 added 6 points to 2114. Bitcoin eased $1 to $237.

Earnings lift markets

|
Upbeat earnings lifted the markets during the midday with Dow gaining 51 points to 18,075. Nasdaq rose 15 points to 5,020.

On the upside

Cien (NYSE: CIEN) will purchase Cyan (NYSE: CYNI) in a transaction valued at approximately $400 million.

CytRx (Nasdaq: CYTR) reported upbeat interim results from two ongoing Phase 1b studies of aldoxorubicin to treat bone cancer.

PMFG (Nasdaq: PMFG) will be acquired by CECO Environmental (Nasdaq: CECE) in a cash and stock deal valued at approximately $150 million.

On the downside

Profit taking weighed down shares of Clean Energy Fuels (Nasdaq: CLNE).

Activist investor Bill Ackman said that he would not discuss CSX (NYSE: CSX) at the Ira Sohn conference sending shares of the railroad operator lower.

Investors locked in profits on Spark Therapeutics (Nasdaq: ONCE).
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on both the NYSE and on Nasdaq. The broader S&P 500 added 5 points to 2114. Bitcoin eased to $238.

Higher open on earnings

|
The markets opened higher with Dow climbing 86 points to 18,110 as investors monitored earnings. Nasdaq gained 33 points to 5,038.

On the upside

InterCloud Systems (Nasdaq: ICLD) launched its Network Functions Virtualization Orchestration platform NFVGrid.

Cognizant Technology Solutions (Nasdaq: CTSH) reported higher first quarter earnings and revenue that topped analyst estimates.

Biocept (Nasdaq: BIOC) launched its c-MET amplification detection test utilizing a blood-based liquid biopsy.

On the downside

Profit taking weighed down share of Syngenta (NYSE: SYT) .

Keryx Biopharmaceuticals (Nasdaq: KERX) widened first quarter losses more than expected as revenue fell.

Halyard Health (NYSE: HYH) disappointed with sharply lower first quarter earnings as revenue fell.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 gained 10 points to 2119. Bitcoin added $1 to $241.
Rising consumer sentiment boosted the markets to a sharply higher close with Dow surging 183 points to 18,024. Nasdaq leaped 63 points to 5,005.

On the upside

Nutrisystem (Nasdaq: NTRI) reported higher first quarter earnings and revenue that beat expectations, forecast current quarter result ahead of estimates and lifted its full year outlook.

Bloomberg reported that Monsanto (NYSE: MON) approached Syngenta (NYSE: SYT) for a possible acquisition.

MRC Global (NYSE: MRC) reported higher first quarter earnings that surpassed expectations.

On the downside

Control4 (Nasdaq: CTRL) widened first quarter losses more than expected.

BioAmber (NYSE: BIOA) priced its offering of 3.9 million common shares at the discounted price of $9.00 per share.

CytRx (Nasdaq: CYTR) fell to a loss for the first quarter.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by nearly 3 to 2 on Nasdaq. The broader S&P 500 soared 22 points to 2108. Bitcoin slipped $1 to $233.
A gain in consumer sentiment lifted the markets during the midday with Dow soaring 122 points to 17,963. Nasdaq climbed 36 points to 4,978.

On the upside

InterCloud Systems (Nasdaq: ICLD) won a professional services contract valued at approximately $3 million and announced that it's backlog of new business has climbed to more $36 million.

Nektar Therapeutics (Nasdaq: NKTR) reversed year ago losses to post a stronger than expected profit for the first quarter.

Ellie Mae (NYSE: ELLI) reported sharply higher first quarter earnings and revenue that surpassed analyst expectations and forecast current quarter as well as full year results ahead of estimates.

On the downside

Accuray (Nasdaq: ARAY) narrowed third quarter losses but the company lowered its full year forecast.

First quarter earnings and revenue fell for Cooper Tire & Rubber (NYSE: CTB) to miss expectations.

Insulet (Nasdaq: PODD) widened first quarter losses more than expected as revenue fell and the company forecast current quarter revenue below estimates.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 climbed 15 points to 2100. Bitcoin slipped $2 to $234.
The markets opened sharply higher with Dow leaping 142 points to 17,982 to recover from yesterday's steep selloff. Nasdaq soared 46 points to 4,987.

On the upside

EnerNOC (Nasdaq: ENOC) will collaborate with Tesla (Nasdaq: TSLA) to deploy and maintain energy storage systems in commercial and industrial buildings.

Ocwen Financial (NYSE: OCN) reported lower first quarter earnings and revenue but the stock price rose.

Shares of Voltari (Nasdaq: VLTC) extended its gains.

On the downside

LinkedIn (NYSE: LNKD) widened losses for the first quarter and forecast current quarter results that fell far short of analyst expectations.

First quarter earnings and revenue rose for Constant Contact (Nasdaq: CTCT) but the company forecast current quarter results below estimates and lowered its full year guidance.

Cumulus Media (Nasdaq: CMLS) widened first quarter losses as revenue fell.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 climbed 14 points to 2100. Bitcoin held steady at $235.

About this Archive

This page is an archive of entries from May 2015 listed from newest to oldest.

April 2015 is the previous archive.

June 2015 is the next archive.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12